Retrospective analysis of squamous cell carcinoma associated with ingenol mebutate reported to the US Food and Drug Administration

Dermatol Ther. 2020 Nov;33(6):e14114. doi: 10.1111/dth.14114. Epub 2020 Sep 2.

Authors

Yu Wang^{1

2}, Shari R Lipner^{1

2}

Affiliations

¹ SUNY Stonybrook Medical School, Stonybrook, New York, USA.
² Department of Dermatology, Weill Cornell Medicine, New York, New York, USA.

PMID: 32735056
DOI: 10.1111/dth.14114

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Squamous Cell* / drug therapy
Diterpenes* / adverse effects
Humans
Keratosis, Actinic*
Retrospective Studies
United States
United States Food and Drug Administration

Substances

3-ingenyl angelate
Diterpenes